Freenome Holdings, Inc.
Overview
Freenome Holdings, Inc. is a biotechnology company focused on developing and deploying early detection blood tests for cancer through the use of machine learning and advanced multiomics. The company's mission is to enable proactive treatment and better outcomes by detecting cancer at an early and manageable stage.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Freenome Holdings, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Freenome Holdings, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.